161 related articles for article (PubMed ID: 16027759)
1. Buproprion, public funding, and smoking cessation.
Bloomfield A
N Z Med J; 2005 Jul; 118(1218):U1576. PubMed ID: 16027759
[No Abstract] [Full Text] [Related]
2. PHARMAC and tobacco control in New Zealand: government policy 'up in smoke'.
Holt S; Harwood M; Aldington S; Beasley R
N Z Med J; 2005 Jun; 118(1216):U1502. PubMed ID: 15937536
[TBL] [Abstract][Full Text] [Related]
3. [Methods and cost effectiveness of nicotine abstinence].
Górecka D
Pol Merkur Lekarski; 2004 May; 16 Suppl 1():79-82. PubMed ID: 15524024
[TBL] [Abstract][Full Text] [Related]
4. The place of pharmacotherapy products in smoking cessation.
Percival J
Prof Nurse; 2003 Oct; 19(2):113-7. PubMed ID: 14593787
[TBL] [Abstract][Full Text] [Related]
5. The "bupropion for smoking cessation" trial from a family practice perspective.
Caplan BJ
Arch Intern Med; 2005 Feb; 165(4):470. PubMed ID: 15738382
[No Abstract] [Full Text] [Related]
6. [Bupropion. An antidepressant used to help smoking cessation].
Taeron C
Rev Infirm; 2002 May; (81):47-9. PubMed ID: 12078615
[No Abstract] [Full Text] [Related]
7. A cost-effectiveness evaluation of single and combined smoking cessation interventions in Texas.
Hill A
Tex Med; 2006 Aug; 102(8):50-5. PubMed ID: 17115560
[No Abstract] [Full Text] [Related]
8. The use of bupropion for smoking cessation in rural New South Wales.
Wong BS; Fraser J
Aust J Rural Health; 2004 Apr; 12(2):38-9. PubMed ID: 15023219
[No Abstract] [Full Text] [Related]
9. Bupropion: risks and benefits.
Ross S; Williams D
Expert Opin Drug Saf; 2005 Nov; 4(6):995-1003. PubMed ID: 16255659
[TBL] [Abstract][Full Text] [Related]
10. More on PHARMAC and tobacco control in New Zealand.
Metcalfe S; Moodie P
N Z Med J; 2006 Jan; 119(1228):U1837. PubMed ID: 16462938
[No Abstract] [Full Text] [Related]
11. The role of pharmacotherapy in assisting smoking cessation.
Waring WS
Eur J Clin Pharmacol; 2003 Sep; 59(5-6):351-6. PubMed ID: 12898083
[TBL] [Abstract][Full Text] [Related]
12. Cost-effective primary care-based strategies to improve smoking cessation: more value for money.
Salize HJ; Merkel S; Reinhard I; Twardella D; Mann K; Brenner H
Arch Intern Med; 2009 Feb; 169(3):230-5; discussion 235-6. PubMed ID: 19204212
[TBL] [Abstract][Full Text] [Related]
13. Sustained-release bupropion for hospital-based smoking cessation: a randomized trial.
Simon JA; Duncan C; Huggins J; Solkowitz S; Carmody TP
Nicotine Tob Res; 2009 Jun; 11(6):663-9. PubMed ID: 19395688
[TBL] [Abstract][Full Text] [Related]
14. PHARMAC and tobacco control in New Zealand: two licensed funded options are already available.
Metcalfe S; Moodie P; McNee W
N Z Med J; 2005 Jun; 118(1217):U1544; author reply U1544; discussion U1544. PubMed ID: 15980915
[No Abstract] [Full Text] [Related]
15. Bupropion for smoking cessation.
Jackson EA
J Fam Pract; 1998 Feb; 46(2):111-2. PubMed ID: 9487309
[No Abstract] [Full Text] [Related]
16. Bupropion and cognitive-behavioral therapy for smoking cessation in women.
Schmitz JM; Stotts AL; Mooney ME; Delaune KA; Moeller GF
Nicotine Tob Res; 2007 Jun; 9(6):699-709. PubMed ID: 17558827
[TBL] [Abstract][Full Text] [Related]
17. [Bupropion: an effective new aid for smoking cessation].
Wagena EJ; Zeegers MP; Huibers MJ; Chavannes NH; van Schayck CP
Ned Tijdschr Geneeskd; 2001 Jan; 145(2):103-4. PubMed ID: 11225253
[No Abstract] [Full Text] [Related]
18. Smoking cessation interventions in clinical practice.
Cornuz J
Eur J Vasc Endovasc Surg; 2007 Oct; 34(4):397-404. PubMed ID: 17681834
[TBL] [Abstract][Full Text] [Related]
19. Heterogeneity in preferences for smoking cessation.
Paterson RW; Boyle KJ; Parmeter CF; Neumann JE; De Civita P
Health Econ; 2008 Dec; 17(12):1363-77. PubMed ID: 18189227
[TBL] [Abstract][Full Text] [Related]
20. Antidepressant drug helps smoking cessation.
Harv Heart Lett; 1998 Feb; 8(6):7-8. PubMed ID: 9516314
[No Abstract] [Full Text] [Related]
[Next] [New Search]
